Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Hold” by Brokerages

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have received an average rating of “Hold” from the twelve analysts that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $5.35.

DH has been the topic of a number of research reports. Stephens initiated coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 target price on the stock. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. The Goldman Sachs Group cut their target price on shares of Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Finally, Barclays cut their target price on shares of Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a research note on Monday, March 3rd.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Nisa Investment Advisors LLC boosted its stake in Definitive Healthcare by 3,652.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock worth $29,000 after acquiring an additional 6,794 shares during the last quarter. Bayesian Capital Management LP bought a new position in Definitive Healthcare during the 4th quarter worth approximately $41,000. Point72 DIFC Ltd lifted its stake in Definitive Healthcare by 759.9% in the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after buying an additional 8,215 shares in the last quarter. Ieq Capital LLC bought a new position in Definitive Healthcare in the fourth quarter valued at approximately $51,000. Finally, KLP Kapitalforvaltning AS bought a new position in Definitive Healthcare in the fourth quarter valued at approximately $54,000. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Trading Up 3.7 %

NASDAQ DH opened at $2.77 on Friday. The stock has a market capitalization of $312.76 million, a P/E ratio of -0.89, a P/E/G ratio of 4.06 and a beta of 1.51. Definitive Healthcare has a 52-week low of $2.55 and a 52-week high of $8.35. The firm has a 50-day moving average price of $4.28 and a 200 day moving average price of $4.35. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH) last issued its earnings results on Thursday, February 27th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.04). The company had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. Equities research analysts expect that Definitive Healthcare will post 0.16 EPS for the current year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.